Use of a biological material containing three-dimensional scaffolds of hyaluronic acid derivatives for the preparation of implants in arthroscopy and kit for instruments for implanting said biological material by arthroscopy

• US 7,722,616 B2
• Filed: 12/27/2001
• Issued: 05/25/2010
• Est. Priority Date: 12/28/2000
• Status: Expired due to Fees

• Current Assignee: Anika Therapeutics Incorporated
• Original Assignee: Fidia Advanced Biopolymers S.R.L. (Anika Therapeutics Incorporated)
• Inventors: Di Fede, Sergio, Marcacci, Maurilio, Callegaro, Lanfranco
• Primary Examiner(s): RAMANA, ANURADHA
• Application Number:
  US10/250,408
• Publication Number:
  US 20040044416A1
• Time in Patent Office: 3,071 Days
• Field of Search: 123/18.11, 123/19.11, 123/19.12, 123/20.14, 123/20.17, 123/20.21, 623/11.11, 623/13.11, 623/16.11, 623/20.15, 623/20.16, 623/23.76, 623/23.74, 623/23.71, 623/23.72, 424/422, 424/423, 435/343
• US Class Current: 606/86.00R
• CPC Class Codes: A61L 27/20 Polysaccharides
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/3852 Cartilage, e.g. meniscus
• CPC Class Codes: C08L 5/08 Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Abstract

The invention relates to use of a biological material containing cells supported on three-dimensional scaffolds containing at least one hyaluronic acid derivative for the preparation of grafts suitable for application by arthroscopy, and a kit of surgical instruments for implanting said biological material by arthroscopy.

Claims

1. A method for the treatment of a cartilage lesion by implantation of a graft at the cartilage lesion site by arthroscopic techniques, said method comprising the steps of:

preparing an autologous and/or allogenic graft comprising a biological material suitable for implantation by arthroscopic techniques, by

growing autologous and/or allogenic cells chosen from the group consisting of chondrocytes, osteocytes, mesenchymal cells, and stem cells onto three-dimensional scaffolds, for a period of time of seven to fourteen days, wherein said scaffolds comprise at least one hyaluronic acid derivative that is an ester of hyaluronic acid, wherein part or all of the carboxy functions of said hyaluronic acid are esterified with alcohols of the arylaliphatic series;

circumscribing the cartilage lesion by creating a circular imprint by means of a mapper-sampler;

cutting out and removing a piece of damaged cartilage tissue having the same size and shape as the imprint;

preparing the so obtained biological material for arthroscopic implantation by reducing said biological material by means of the mapper-sampler to the size and shape of said imprint;

introducing the so reduced biological material into a cannula and applying the same to the cartilage lesion site.

2. The method according to claim 1, further comprising the step of adding one or more pharmaceutically or biologically active ingredients onto said three-dimensional scaffolds before the step of growing said autologous and/or allogenic cells.

3. The method according to claim 1, further comprising the cryopreservation of the said biological material before the step of preparing it for arthroscopic implantation in order to preserve the characteristics of cell viability ready for grafts to be performed at a future time.

4. The method according to claim 1, wherein said three-dimensional scaffolds are in the form of a non-woven fabric.

5. The method according to claim 1, wherein said three-dimensional scaffolds comprise a total benzyl ester of hyaluronic acid.

6. The method according to claim 1, wherein said three-dimensional scaffolds further comprise one or more pharmaceutically or biologically active ingredients.

7. The method according to claim 1, wherein said three-dimensional scaffolds consist of an ester of hyaluronic acid, wherein part or all of the carboxy functions are esterified with alcohols of the arylaliphatic series.

8. The method according to claim 7, wherein said three-dimensional scaffolds consist of a total benzyl ester of hyaluronic acid.

9. The method according to claim 7, wherein said three-dimensional scaffolds are in the form of a non-woven fabric.

10. The method according to claim 7, wherein said three-dimensional scaffolds consist of an ester of hyaluronic acid, wherein part or all of the carboxy functions are esterified with alcohols of the arylaliphatic series.

11. The method according to claim 10, wherein said three-dimensional scaffolds consist of a total benzyl ester of hyaluronic acid.